| [1] Maier L M. Genetic susceptibility to type 1 diabetes[J]. Curr Opin Immunol, 2005, 17(6): 601-608.[2] Garcia M J, McNamara P M, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study[J]. Diabet, 1974, 23(2): 105-111.[3] Kleinman J C, Donahue R P, Harris M I, et al. Mortality among diabetics in a national sample[J]. Am J Epidemiol, 1988, 128(2): 389-401.[4] Krolewski A S, Czyzyk A, Janeczko D, et al. Mortality from cardiovascular diseases among diabetics[J]. Diabetologia, 1977, 13(4): 345-350.[5] American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabet Care, 2004, 27 (Suppl 1): S5-S10.[6] Roglic G, Unwin N, Bennett P H, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000[J]. Diabet Care, 2005, 28(9): 2 130-2 135.[7] Maria P S, Ronald B G. Lipid management in type 2 diabetes[J]. Clin Diabet, 2006, 24(1): 27-32.[8] Georg P, Ludvik B. Lipids and diabetes[J]. J Clin Basic Cardiol, 2000, 3(3): 159-162.[9] Haffner S M, Stern M P, Hazuda H P, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?[J]. J Am Med Assoc, 1990, 263(21): 2 893-2 898.[10] He Q H, Ren P P, Kong X F, et al. Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach[J]. J Nutri Biochem, 2012, 23(2): 133-139.[11] Xu W X, Wu J F, An Y P, et al. Streptozotocin-induced dynamic metabonomic changes in rat biofluids[J]. J Proteome Res, 2012, DOI:10.1021/pr300280t.[12] Zhang X Y, Wang Y L, Hao F H, et al. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses[J]. J Proteome Res, 2009, 8(11): 5 188-5 195.[13] Mary K C, Shawn O F. Biochemistry(5th ed)[M]. New York: Brooks, 2006.[14] Serkova N J, Jackman M, Brown J L, et al. Metabolic profiling of livers and blood from obese Zucker rats[J]. J Hepato, 2006, 44(5): 956-962.[15] Lewis L A. Blood lipids and lipoproteins: quantitation, composition, and metabolism.[J]. Clinic Chem, 1973, 19(6): 690-691.[16] Rakieten N, Rakieten M L.Nadkarni M V. Studies on the diabetogenic action of streptozotocin (NSC-37917)[J]. Cancer Chemother Rep, 1963, 29(1): 91-98.[17] Elsner M, Guldbakke B, Tiedge M, et al. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin[J]. Diabetologia, 2000, 43(12): 1 528-1 533.[18] Zhang S C, Gowda G A N, Asiago V, et al. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats[J]. Anal Biochem, 2008, 383(1): 76-84.[19] Junod A, Lambert A E, Stauffacher W, et al. Diabetogenic action of streptozotocin: relationship of dose to metabolic response[J]. J Clin Invest, 1969, 48(11): 2 129-2 139.[20] Fan T W M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures[J]. Prog Nucl Magn Reson Spect, 1996, 28(1996): 161-219.[21] Nicholson J K, Foxall P J, Spraul M, et al. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma[J]. Anal Chem, 1995, 67(5): 793-811.[22] Beckwith-Hall B M, Thompson N A, Nicholson J K, et al. A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum[J]. Analyst, 2003, 128(7): 814-818.[23] Maritim A C, Sanders R A.Watkins J B. Diabetes, oxidative stress, and antioxidants: a review[J]. J Biochem Mol Toxic, 2003, 17(1): 24-38.[24] Biddinger S B, Miyazaki M, Boucher J, et al. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein1c[J]. Diabet, 2006, 55(7): 2 032-2 041.[25] Boyko E J, Leonetti D L, Bergstrom R W, et al. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men[J]. Diabet, 1996, 45(8): 1 010-1 015.[26] Bj-rntorp P. Regional fat distribution: implications for type II diabetes[J]. Int J Obes Relat Metab Disord, 1992, 16(Suppl 4): S19-S27.[27] Jane E A. Fatty acid composition of fat depots in wintering Canada geese[J]. Wilson Bull, 1993, 105(2): 339-347. |
